Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Day

Showing results (421-430 of 440) with videos related to

Pageof 44
Sort By:
Plos One|November 20, 2008
Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assayRobert Grützmann, Bela Molnar, Christian Pilarsky, et al.
Physical Review Letters|May 23, 2020
Demonstration of Scale-Invariant Rayleigh-Taylor Instability Growth in Laser-Driven Cylindrical Implosion ExperimentsJ P Sauppe, S Palaniyappan, B J Tobias, et al.
BMC Genetics|January 21, 2017
Fat mass and obesity associated (FTO) gene influences skeletal muscle phenotypes in non-resistance trained males and elite rugby playing positionS M Heffernan, G K Stebbings, L P Kilduff, et al.
International Journal of Sports Physiology and Performance|June 5, 2021
Genetic Polymorphisms Related to VO2max Adaptation Are Associated With Elite Rugby Union Status and Competitive Marathon PerformanceElliott C R Hall, Sandro S Almeida, Shane M Heffernan, et al.
Journal of Medicinal Chemistry|May 12, 2017
Discovery of a Potent Nonpeptidomimetic, Small-Molecule Antagonist of Cellular Inhibitor of Apoptosis Protein 1 (cIAP1) and X-Linked Inhibitor of Apoptosis Protein (XIAP)Emiliano Tamanini, Ildiko M Buck, Gianni Chessari, et al.
Journal of Medicinal Chemistry|July 29, 2015
Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Discovery of a Non-Alanine Lead Series with Dual Activity Against cIAP1 and XIAPGianni Chessari, Ildiko M Buck, James E H Day, et al.
ACS Medicinal Chemistry Letters|July 21, 2015
Fragment-Based Discovery of Potent and Selective DDR1/2 InhibitorsChristopher W Murray, Valerio Berdini, Ildiko M Buck, et al.
Physiological Genomics|January 14, 2016
Association of ACTN3 R577X but not ACE I/D gene variants with elite rugby union player status and playing positionS M Heffernan, L P Kilduff, R M Erskine, et al.
Journal of Medicinal Chemistry|August 10, 2018
A Fragment-Derived Clinical Candidate for Antagonism of X-Linked and Cellular Inhibitor of Apoptosis Proteins: 1-(6-[(4-Fluorophenyl)methyl]-5-(hydroxymethyl)-3,3-dimethyl-1 H,2 H,3 H-pyrrolo[3,2- b]pyridin-1-yl)-2-[(2 R,5 R)-5-methyl-2-([(3R)-3-methylmorpholin-4-yl]methyl)piperazin-1-yl]ethan-1-one (ASTX660)Christopher N Johnson, Jong Sook Ahn, Ildiko M Buck, et al.
Science (New York, N.Y.)|October 26, 2013
Ecosystem services: responseIan J Bateman, Amii R Harwood, Georgina M Mace, et al.
Pageof 44

Showing results (421-430 of 440) with videos related to

Sort By:
Pageof 44
Plos One|November 20, 2008
Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assayRobert Grützmann, Bela Molnar, Christian Pilarsky, et al.
Physical Review Letters|May 23, 2020
Demonstration of Scale-Invariant Rayleigh-Taylor Instability Growth in Laser-Driven Cylindrical Implosion ExperimentsJ P Sauppe, S Palaniyappan, B J Tobias, et al.
BMC Genetics|January 21, 2017
Fat mass and obesity associated (FTO) gene influences skeletal muscle phenotypes in non-resistance trained males and elite rugby playing positionS M Heffernan, G K Stebbings, L P Kilduff, et al.
International Journal of Sports Physiology and Performance|June 5, 2021
Genetic Polymorphisms Related to VO2max Adaptation Are Associated With Elite Rugby Union Status and Competitive Marathon PerformanceElliott C R Hall, Sandro S Almeida, Shane M Heffernan, et al.
Journal of Medicinal Chemistry|May 12, 2017
Discovery of a Potent Nonpeptidomimetic, Small-Molecule Antagonist of Cellular Inhibitor of Apoptosis Protein 1 (cIAP1) and X-Linked Inhibitor of Apoptosis Protein (XIAP)Emiliano Tamanini, Ildiko M Buck, Gianni Chessari, et al.
Journal of Medicinal Chemistry|July 29, 2015
Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Discovery of a Non-Alanine Lead Series with Dual Activity Against cIAP1 and XIAPGianni Chessari, Ildiko M Buck, James E H Day, et al.
ACS Medicinal Chemistry Letters|July 21, 2015
Fragment-Based Discovery of Potent and Selective DDR1/2 InhibitorsChristopher W Murray, Valerio Berdini, Ildiko M Buck, et al.
Physiological Genomics|January 14, 2016
Association of ACTN3 R577X but not ACE I/D gene variants with elite rugby union player status and playing positionS M Heffernan, L P Kilduff, R M Erskine, et al.
Journal of Medicinal Chemistry|August 10, 2018
A Fragment-Derived Clinical Candidate for Antagonism of X-Linked and Cellular Inhibitor of Apoptosis Proteins: 1-(6-[(4-Fluorophenyl)methyl]-5-(hydroxymethyl)-3,3-dimethyl-1 H,2 H,3 H-pyrrolo[3,2- b]pyridin-1-yl)-2-[(2 R,5 R)-5-methyl-2-([(3R)-3-methylmorpholin-4-yl]methyl)piperazin-1-yl]ethan-1-one (ASTX660)Christopher N Johnson, Jong Sook Ahn, Ildiko M Buck, et al.
Science (New York, N.Y.)|October 26, 2013
Ecosystem services: responseIan J Bateman, Amii R Harwood, Georgina M Mace, et al.
Pageof 44